Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

0.9110
+0.03504.00%
Post-market: 0.94800.0370+4.06%18:48 EDT
Volume:119.80K
Turnover:108.63K
Market Cap:13.71M
PE:-2.17
High:0.9357
Open:0.8600
Low:0.8500
Close:0.8760
Loading ...
Aug 07, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 27, 2023

Major Issues Report

Form 8-K - Current report
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 14, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 07, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 01, 2023

Correspondence

Form CORRESP - Correspondence
Jun 01, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Correspondence

Form CORRESP - Correspondence
May 10, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933